Pages that link to "Item:Q3136906"
Jump to navigation
Jump to search
The following pages link to University of Navarre (Q3136906):
Displayed 28 items.
- Validation of the prometstatic protein TMPRSS4 as a poor prognosis factor in NSCLC. Development of therapeutic tools and drugs for their inhibition (Q3199892) (← links)
- Reduction of the radiation dose received by the patient in PET/CT studies (Q3201446) (← links)
- Study of the interaction of adipokines and myoquins in the development of obesity and associated comorbidities (Q3201518) (← links)
- Identification of new alterations in myelodysplastic syndrome at risk of progression to acute myeloid leukemia: biomarkers and new therapeutic targets using NGS (Q3201978) (← links)
- Vaccination against bacterial dysentery using intranasal patches (Q3202572) (← links)
- Modulating the immune system with oncolytic adenovirus as a strategy for diffuse stem tumors (DIPGs) (Q3202585) (← links)
- Spanish Clinical Research Network (SCReN) (Q3204816) (← links)
- JNK1, a potential therapeutic target in Alzheimer’s disease (Q3209412) (← links)
- Allergens and Pharmacists Adverse Reaction Research Network (Q3209471) (← links)
- LIFESTYLES AND RISK OF GESTATIONAL DIABETES MELLITUS: THE SUN COHORT (Q3210400) (← links)
- Role of interleukin 32 in regulating the polarisation of macrophages in adipose tissue. Involvement in the development of inflammation and comorbidities associated with obesity. (Q3211266) (← links)
- PLATFORM OF CLINICAL RESEARCH UNITS AND CLINICAL TRIALS (Q3211491) (← links)
- Boosting innovation in the early detection of hearing loss in children within SUDOE space: Towards a personalized medicine based on genomic diagnostic tools (Q4302253) (← links)
- Development of innovative formulations with mucoadhesive nanoparticles for the treatment of mucosal ulcers (NANOMUC) (Q4664195) (← links)
- USE OF MUCOADHESIVE POLYMER FORMULATIONS FOR THE ERADICATION OF HELICOBACTER PYLORI (Q4664993) (← links)
- Automatic CAR T cell production platforms for the treatment of B leukemia and B lymphoma (Q4665431) (← links)
- Research on the pharmacological efficacy of unsaturated fatty acids designed for the treatment of Alzheimer’s disease (IGRALZHEIMER) (Q4686078) (← links)
- Elaboration AND IMPLEMENTATION OF STRATIFICING TOOLS OF RISKS IN COMPLETED CRONIC PACIENTS (Stratistics) (Q4686638) (← links)
- Circular system for the recovery and agronomic valuation of phosphorus (Q4686853) (← links)
- Clinical development of a cell therapy for heart repair based on tissue engineering (Q4688501) (← links)
- Development of an oral immunotherapy based on nanoparticles for the treatment of food allergies (Q4688728) (← links)
- Clinical development of a therapeutic vaccine for the treatment of cervical dysplasias (Q4690425) (← links)
- LOW FREQUENCY CAR2CAR COMMUNICATION (Q4692486) (← links)
- Innovative drugs for the treatment of Alzheimer’s disease: Preclinical studies of efficacy and toxicity under oral BPL conditions (Q4693398) (← links)
- IDP4SCLC Drug Optimisation in New IDP Therapeutic Targets (ASCL1) for the Treatment of Microcytic Lung Cancer (Q4695136) (← links)
- NAVARRA-PROY INVESTIG UNIVERSITY. MOD TO 2018/2020 (Q6844107) (← links)
- Search for new targets and therapeutic strategies in a model of leishmaniasis. (Q6844110) (← links)
- New therapeutic strategy to prevent immune escape in metastatic lung cancer (Q6844280) (← links)